OnKure Therapeutics, Inc. OKUR Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$58.75M+0.5% | -$59.52M-13.0% | -$63.46M— | -$60.31M— | -$59.06M— | ||
| $433K-6.5% | $447K-2.6% | $459K-27.6% | $465K-17.4% | $463K-5.5% | ||
| $11.67M+62.8% | $11.63M+157% | $11.15M— | $8.26M— | $7.17M— | ||
| -$50.76M+6.8% | -$51.83M-1.4% | -$63.67M— | -$61.29M— | -$54.49M— | ||
| $33K-45.9% | $46K-11.5% | $52K-40.2% | $64K-27.3% | $61K-26.5% | ||
| -$33K-100% | -$46K-100% | $15.87M— | $15.86M— | $15.86M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $116.04M— | ||
| $95.45M+23.3% | -$51.71M-164% | $62.37M+1,254% | $64.74M+261% | $77.41M+2,902% | ||
| -$50.79M+6.9% | -$51.87M-1.4% | -$63.72M— | -$61.36M— | -$54.55M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does OnKure Therapeutics, Inc. generate?
- OnKure Therapeutics, Inc. (OKUR) generated -$50.8M in operating cash flow over the trailing twelve months.
- What is OnKure Therapeutics, Inc.'s free cash flow?
- After $33.0K of capital expenditures, OnKure Therapeutics, Inc.'s free cash flow was -$50.8M over the trailing twelve months, up 6.9% year over year.
- Where does OnKure Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.